In this issue: Message from the Chair and CEO ~ Nova Scotia Pharmacy Conference 2017 ~ Ask a Drug Information Pharmacist: Is Triple Antithrombotic Therapy Appropriate for some Cardiovascular Patients? ~ Ask a Drug Information Pharmacist: Can Testosterone be used in Women?
For Immediate Release
Dartmouth, NS - A recent study shows that comprehensive care provided by pharmacists to patients with high blood pressure can increase patients’ life span while providing significant savings to the health care system.
With online voting it is now simpler to cast your vote for our 2016 Board of Directors election. Simply Voting is a highly reputable system that ensures tamper proof balloting and security of voter information. Your vote will be completely confidential.
Click on the picture above or here to download the full May 2016 edition of The Pharmacist.
Pharmacist Kelly MacIsaac and pharmacy technician Karen Leyte’s partnership has existed for more than 20 years. The pair started working together at the Nova Scotia Hospital and the partnership continued at the Dartmouth General Hospital three years ago when the pharmacy department was closed at the Nova Scotia Hospital.
One of the main programs they work together on is the Provincial Clozapine Program. To fully understand the importance of Kelly and Karen’s partnership, a brief background of Clozapine is required.
Pharmacist and Pharmacy Professor Natalie Kennie-Kaulbach's first job as a pharmacist was on a Family Medicine Team at St. Michael's Hospital in Toronto. This was after the Nova Scotia native completed her pharmacy degree at Dalhousie University and a Doctor of Pharmacy at the University of Toronto.
Hospital pharmacist Steve Allen works in two areas. He’s the clinical pharmacist for cardiology in the Coronary Care Unit (CCU) and he works with the Hematology Department covering the Warfarin Clinic.
The CCU cares for patients with heart failure, rhythm problems, and patients who have had a heart attack. Steve "rounds" with the medical team, provides advice on appropriate drug therapy and dosage, helps to identify potential drug-related problems, and ensures patients can afford their medications after they leave the hospital.
As of January 3rd, 2019 we are aware of the following coverage for smoking cessation: